PT2471905T - Populações de células estaminais placentárias - Google Patents

Populações de células estaminais placentárias

Info

Publication number: PT2471905T
Authority: PT; Portugal
Prior art keywords: stem cell; cell populations; placental stem; placental; populations
Prior art date: 2005-12-29

Application number

PT12150924T

Other languages

English (en)

Inventor

W Edinger James

Wang Jia-Lun

Ye Qian

Faleck Herbert

Dawn Abramson Sascha

J Hariri Robert

S Labazzo Kristen

Periera Marian

Original Assignee

Celularity Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-29

Filing date

2006-12-28

Publication date

2019-01-11

2006-12-28 Application filed by Celularity Inc filed Critical Celularity Inc

2019-01-11 Publication of PT2471905T publication Critical patent/PT2471905T/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/42—Organic phosphate, e.g. beta glycerophosphate
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Developmental Biology & Embryology (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Immunology (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Insects & Arthropods (AREA)
Diabetes (AREA)
Virology (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Animal Husbandry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dermatology (AREA)
Neurosurgery (AREA)
Neurology (AREA)

PT12150924T 2005-12-29 2006-12-28 Populações de células estaminais placentárias PT2471905T (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US75496805P	2005-12-29	2005-12-29
US84664106P	2006-09-22	2006-09-22

Publications (1)

Publication Number	Publication Date
PT2471905T true PT2471905T (pt)	2019-01-11

Family

ID=38069162

Family Applications (5)

Application Number	Title	Priority Date	Filing Date
PT12150928T PT2471906T (pt)	2005-12-29	2006-12-28	Populações de células estaminais da placenta
PT12150924T PT2471905T (pt)	2005-12-29	2006-12-28	Populações de células estaminais placentárias
PT12150919T PT2471904T (pt)	2005-12-29	2006-12-28	População de células estaminais placentárias
PT121509129T PT2471903T (pt)	2005-12-29	2006-12-28	População de células estaminais placentárias
PT12150934T PT2471907T (pt)	2005-12-29	2006-12-28	Populações de células estaminais placentárias

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PT12150928T PT2471906T (pt)	2005-12-29	2006-12-28	Populações de células estaminais da placenta

Family Applications After (3)

Application Number	Title	Priority Date	Filing Date
PT12150919T PT2471904T (pt)	2005-12-29	2006-12-28	População de células estaminais placentárias
PT121509129T PT2471903T (pt)	2005-12-29	2006-12-28	População de células estaminais placentárias
PT12150934T PT2471907T (pt)	2005-12-29	2006-12-28	Populações de células estaminais placentárias

Country Status (18)

Country	Link
US (7)	US20080032401A1 (pt)
EP (7)	EP2471904B1 (pt)
JP (2)	JP5550235B2 (pt)
KR (9)	KR101900809B1 (pt)
CN (5)	CN103146640B (pt)
AU (1)	AU2006332678B2 (pt)
CA (2)	CA2957336C (pt)
DK (5)	DK2471904T3 (pt)
ES (6)	ES2671355T3 (pt)
HK (1)	HK1184817A1 (pt)
IL (6)	IL192457A0 (pt)
MX (4)	MX2020001944A (pt)
NZ (4)	NZ595786A (pt)
PE (1)	PE20080146A1 (pt)
PL (6)	PL2471907T3 (pt)
PT (5)	PT2471906T (pt)
WO (1)	WO2007079183A2 (pt)
ZA (2)	ZA201004182B (pt)

Families Citing this family (186)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1349918T3 (da)	2000-12-06	2014-11-10	Anthrogenesis Corp	Fremgangsmåde til indsamling af stamceller fra moderkagen
US20080152629A1 (en) *	2000-12-06	2008-06-26	James Edinger	Placental stem cell populations
US7311905B2 (en) *	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
KR101132545B1 (ko)	2001-02-14	2012-04-02	안트로제네시스 코포레이션	산후 포유류의 태반, 이의 용도 및 태반 줄기세포
CA3046566A1 (en)	2001-02-14	2002-08-22	Anthrogenesis Corporation	Post-partum mammalian placental stem cells for use in the treatment of neurological or renal diseases and disorders
US7498171B2 (en)	2002-04-12	2009-03-03	Anthrogenesis Corporation	Modulation of stem and progenitor cell differentiation, assays, and uses thereof
EP1571910A4 (en) *	2002-11-26	2009-10-28	Anthrogenesis Corp	CYTOTHERAPEUTIC AGENTS, CYTOTHERAPEUTIC UNITS AND METHODS OF TREATMENT IN WHICH THEY INTERVENE
US9579351B2 (en)	2003-06-27	2017-02-28	DePuy Synthes Products, Inc.	Postpartum cells derived from placental tissue, and methods of making and using the same
US9592258B2 (en)	2003-06-27	2017-03-14	DePuy Synthes Products, Inc.	Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US8790637B2 (en)	2003-06-27	2014-07-29	DePuy Synthes Products, LLC	Repair and regeneration of ocular tissue using postpartum-derived cells
US9572840B2 (en)	2003-06-27	2017-02-21	DePuy Synthes Products, Inc.	Regeneration and repair of neural tissue using postpartum-derived cells
US8518390B2 (en)	2003-06-27	2013-08-27	Advanced Technologies And Regenerative Medicine, Llc	Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
US7875272B2 (en) *	2003-06-27	2011-01-25	Ethicon, Incorporated	Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US8491883B2 (en)	2003-06-27	2013-07-23	Advanced Technologies And Regenerative Medicine, Llc	Treatment of amyotrophic lateral sclerosis using umbilical derived cells
GB0321337D0 (en) *	2003-09-11	2003-10-15	Massone Mobile Advertising Sys	Method and system for distributing advertisements
KR20110116225A (ko) *	2003-12-02	2011-10-25	셀진 코포레이션	혈색소병증　및　빈혈의　치료　및　관리를　위한　방법및　조성물
US20050176139A1 (en) *	2004-01-12	2005-08-11	Yao-Chang Chen	Placental stem cell and methods thereof
US20050276792A1 (en) *	2004-03-26	2005-12-15	Kaminski Joseph K	Systems and methods for providing a stem cell bank
ES2621847T3 (es)	2004-12-23	2017-07-05	DePuy Synthes Products, Inc.	Células posparto derivadas de tejido de cordón umbilical, y métodos de elaboración y uso de las mismas
DK1835924T3 (da)	2004-12-23	2013-11-04	Ethicon Inc	Behandling af parkinsons sygdom og beslægtede sygdomme under anvendelse af postpartum opnåede celler
US20100028312A1 (en) *	2005-03-24	2010-02-04	Caritas St. Elizabeth Medical Center of Boston Inc	Stably transformed bone marrow-derived cells and uses thereof
CA2856662C (en)	2005-10-13	2017-09-05	Anthrogenesis Corporation	Immunomodulation using placental stem cells
EP1934334A1 (en) *	2005-10-13	2008-06-25	Anthrogenesis Corporation	Production of oligodendrocytes from placenta-derived stem cells
JP5289970B2 (ja)	2005-12-16	2013-09-11	エシコン・インコーポレイテッド	組織適合性不適合な移植における逆免疫反応を抑制するための組成物および方法
US8741638B2 (en)	2005-12-19	2014-06-03	DePuy Synthes Products, LLC	In vitro expansion of postpartum-derived cells in roller bottles
US9125906B2 (en)	2005-12-28	2015-09-08	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
PT2471906T (pt)	2005-12-29	2019-02-06	Celularity Inc	Populações de células estaminais da placenta
WO2007079185A2 (en) *	2005-12-29	2007-07-12	Anthrogenesis Corporation	Improved composition for collecting and preserving placental stem cells and methods of using the composition
CN101389754A (zh) *	2005-12-29	2009-03-18	人类起源公司	胎盘干细胞和第二来源干细胞的联合培养
US9944900B2 (en) *	2006-01-18	2018-04-17	Hemacell Perfusion	Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells
CA2909053C (en) *	2006-05-11	2021-02-09	Cord Blood Science Inc.	Methods for collecting and using placenta cord blood stem cells
US20080050814A1 (en) *	2006-06-05	2008-02-28	Cryo-Cell International, Inc.	Procurement, isolation and cryopreservation of fetal placental cells
US7993918B2 (en) *	2006-08-04	2011-08-09	Anthrogenesis Corporation	Tumor suppression using placental stem cells
US8372437B2 (en)	2006-08-17	2013-02-12	Mimedx Group, Inc.	Placental tissue grafts
AU2007309447B2 (en) *	2006-10-23	2014-04-03	Celularity Inc.	Methods and compositions for treatment of bone defects with placental cell populations
US8221741B2 (en)	2007-01-17	2012-07-17	Marshall Vivienne S	Methods for modulating inflammatory and/or immune responses
MX2009008559A (es)	2007-02-12	2009-08-21	Anthrogenesis Corp	Hepatocitos y condorcitos de celulas madre de la placenta adherentes, y poblaciones de celulas enriquecidas con celulas madre de la placenta cd34+, cd45-.
CN101657206B (zh) *	2007-02-12	2013-07-03	人类起源公司	利用胎盘干细胞治疗炎性疾病
WO2008109816A1 (en) *	2007-03-08	2008-09-12	Hemacell Perfusion, Inc.	Method for isolation of afterbirth derived cells
US20100172830A1 (en) *	2007-03-29	2010-07-08	Cellx Inc.	Extraembryonic Tissue cells and method of use thereof
WO2008156659A1 (en)	2007-06-18	2008-12-24	Children's Hospital & Research Center At Oakland	Method of isolating stem and progenitor cells from placenta
EP2014294A1 (en) *	2007-07-13	2009-01-14	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Use of CD200 as a mesenchymal stem cells marker
US20100129328A1 (en) *	2007-07-24	2010-05-27	Sing George L	Methods for promoting hair growth
US9200253B1 (en)	2007-08-06	2015-12-01	Anthrogenesis Corporation	Method of producing erythrocytes
EP3689421B1 (en)	2007-09-07	2025-02-19	MiMedx Group, Inc.	Placental tissue grafts and improved methods of preparing and using the same
US10925903B2 (en)	2007-09-13	2021-02-23	Reprobiogen Inc.	Use of cells derived from first trimester umbilical cord tissue
MX2008005751A (es) *	2007-09-13	2009-04-16	Clifford L Librach	Metodo de aislamiento y uso de celulas derivadas del tejido del cordon umbilical del primer trimestre.
US12129481B2 (en)	2007-09-13	2024-10-29	Reprobiogen Inc.	Use of cells derived from first trimester umbilical cord tissue
CN107028981B (zh)	2007-09-19	2021-04-20	普拉里斯坦有限公司	来自脂肪或胎盘组织的粘附细胞及其在治疗中的用途
CA2700613C (en) *	2007-09-26	2022-09-20	Celgene Cellular Therapeutics	Angiogenic cells from human placental perfusate
EP3524253A1 (en)	2007-09-28	2019-08-14	Celularity, Inc.	Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
EP2203186B1 (en)	2007-10-05	2014-09-24	DePuy Synthes Products, LLC	Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells
KR20100100855A (ko) *	2007-11-07	2010-09-15	안트로제네시스 코포레이션	조산 합병증의 치료에 있어서의 제대혈의 용도
US8455251B2 (en)	2007-11-09	2013-06-04	Rnl Bio Co., Ltd.	Method for isolating and culturing adult stem cells derived from human amniotic epithelium
US8236538B2 (en)	2007-12-20	2012-08-07	Advanced Technologies And Regenerative Medicine, Llc	Methods for sterilizing materials containing biologically active agents
EP2250497B1 (en) *	2008-02-18	2014-09-10	Genetic Technologies Limited	Cell processing and/or enrichment methods
US9458431B2 (en)	2008-03-17	2016-10-04	Agency For Science, Technology And Research	Microcarriers for stem cell culture
US8716018B2 (en)	2008-03-17	2014-05-06	Agency For Science, Technology And Research	Microcarriers for stem cell culture
US20120028352A1 (en) *	2008-03-17	2012-02-02	Agency For Science, Technology And Research	Microcarriers for Stem Cell Culture
US8497122B2 (en)	2008-04-11	2013-07-30	Washington University	Biomarkers for Niemann-pick C disease and related disorders
DK2727998T3 (da) *	2008-04-21	2019-08-26	Viacyte Inc	Fremgangsmåder til oprensning af pancreatiske endodermceller afledt fra humane embryoniske stamceller
AU2009252722A1 (en) *	2008-05-27	2009-12-03	Pluristem Ltd.	Methods of treating inflammatory colon diseases
MX339624B (es) *	2008-08-20	2016-06-02	Anthrogenesis Corp	Composiciones mejoradas de celulas y metodos para preparar las mismas.
WO2010021715A1 (en) *	2008-08-20	2010-02-25	Anthrogenesis Corporation	Treatment of stroke using isolated placental cells
ES2426241T3 (es)	2008-08-22	2013-10-22	Anthrogenesis Corporation	Métodos y composiciones para el tratamiento de defectos óseos con poblaciones de células placentarias
US20110256108A1 (en) *	2008-09-02	2011-10-20	Moran Meiron	Methods of selection of cells for transplantation
US9096827B2 (en) *	2008-09-02	2015-08-04	Pluristem Ltd.	Adherent cells from placenta tissue and use thereof in therapy
US8524496B2 (en) *	2008-09-02	2013-09-03	Pluristem Ltd.	Adherent cells from placenta tissue and use thereof in therapy
WO2010040262A1 (zh) *	2008-10-10	2010-04-15	深圳市嘉天源生物科技有限公司	分离动物胚胎间质性干细胞并提取其分泌物的方法
WO2010043076A1 (zh) *	2008-10-17	2010-04-22	宁夏医科大学附属医院	适于临床应用的人胎盘间质细胞库的建立方法
RU2562154C2 (ru) *	2008-11-19	2015-09-10	Антродженезис Корпорейшн	Амниотические адгезивные клетки
EP2375907B1 (en) *	2008-11-21	2019-02-27	Celularity, Inc.	Treatment of diseases, disorders or conditions of the lung using placental cells
BRPI0923068B1 (pt)	2008-12-19	2021-05-25	Advanced Technologies And Regenerative Medicine, Llc	Uso de células derivadas de tecido de cordão umbilical para tratar um paciente tendo uma doença, distúrbio ou injúria pulmonar
US10179900B2 (en)	2008-12-19	2019-01-15	DePuy Synthes Products, Inc.	Conditioned media and methods of making a conditioned media
US8771677B2 (en)	2008-12-29	2014-07-08	Vladimir B Serikov	Colony-forming unit cell of human chorion and method to obtain and use thereof
CA2756594C (en)	2009-03-25	2021-03-23	Anthrogenesis Corporation	Treatment of viral infection using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
WO2010111663A1 (en)	2009-03-26	2010-09-30	Ethicon, Inc.	Human umbilical cord tissue cells as therapy for alzheimer' s disease
CA2795268A1 (en)	2009-04-21	2010-10-28	Genetic Technologies Limited	Methods for obtaining fetal genetic material
WO2010141654A1 (en) *	2009-06-05	2010-12-09	Anthrogenesis Corporation	Improved method of collecting placental cells
US8796315B2 (en)	2009-06-25	2014-08-05	Darlene E. McCord	Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
US8586360B2 (en)	2009-07-02	2013-11-19	Anthrogenesis Corporation	Method of producing erythrocytes without feeder cells
CN101942413B (zh) *	2009-07-07	2015-02-11	翁炳焕	出生缺陷细胞库及其构建方法
US8647617B2 (en)	2009-07-13	2014-02-11	Stemnion, Inc.	Methods for modulating inflammatory and/or immune responses
SG10201403202XA (en) *	2009-07-23	2014-08-28	Agency Science Tech & Res	Pre-natal mesenchymal stem cells
GB2487339A (en) *	2009-10-23	2012-07-18	Amorcyte Inc	Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
EP3284818B1 (en) *	2010-01-26	2022-03-09	Celularity Inc.	Treatment of bone-related cancers using placental stem cells
WO2011103462A1 (en)	2010-02-18	2011-08-25	Osiris Therapeutics, Inc.	Methods of manufacture of immunocompatible amniotic membrane products
RS55287B1 (sr) *	2010-04-07	2017-03-31	Anthrogenesis Corp	Angiogeneza korišćenjem matičnih ćelija iz placente
AU2013203479B2 (en) *	2010-04-07	2016-05-19	Celularity Inc.	Angiogenesis using placental stem cells
TW201138792A (en)	2010-04-08	2011-11-16	Anthrogenesis Corp	Treatment of sarcoidosis using placental stem cells
US8883210B1 (en)	2010-05-14	2014-11-11	Musculoskeletal Transplant Foundation	Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en)	2010-05-14	2016-05-31	Musculoskeletal Transplant Foundation	Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en)	2010-05-14	2018-11-20	Musculoskeletal Transplant Foundation	Tissue-derived tissuegenic implants, and methods of fabricating and using same
AU2011279201B2 (en)	2010-07-13	2016-01-21	Celularity Inc.	Methods of generating natural killer cells
KR101211913B1 (ko) *	2010-07-16	2012-12-13	주식회사 알앤엘바이오	양막유래 중간엽 줄기세포 배양을 위한 배지조성물 및 이를 이용한 양막유래 중간엽 줄기세포의 배양방법
JP2014507390A (ja) *	2010-12-17	2014-03-27	アントフロゲネシスコーポレーション	胎盤幹細胞を用いる脊髄損傷及び外傷性脳損傷の治療
US8574899B2 (en)	2010-12-22	2013-11-05	Vladimir B Serikov	Methods for augmentation collection of placental hematopoietic stem cells and uses thereof
AR084754A1 (es) *	2010-12-30	2013-06-05	Anthrogenesis Corp	Composiciones que comprenden celulas madre de placenta y plasma rico en plaquetas, y sus metodos de uso
AR084753A1 (es)	2010-12-30	2013-06-05	Anthrogenesis Corp	Composiciones que comprenden celulas adherentes derivadas del saco amniotico (amdac) y plasma rico en plaquetas (prp)
WO2012092485A1 (en)	2010-12-31	2012-07-05	Anthrogenesis Corporation	Enhancement of placental stem cell potency using modulatory rna molecules
US20140017209A1 (en) *	2011-03-22	2014-01-16	Pluristem Ltd.	Methods for treating radiation or chemical injury
KR101835917B1 (ko)	2011-03-22	2018-03-07	플루리스템 리미티드	방사선 또는 화학적 손상을 치료하는 방법들
US20120276215A1 (en) *	2011-04-26	2012-11-01	Riordan Neil H	Therapeutic Conditioned Media
WO2012166844A2 (en) *	2011-06-01	2012-12-06	Anthrogenesis Corporation	Treatment of pain using placental stem cells
CN104470529A (zh) *	2011-07-15	2015-03-25	人类起源公司	利用羊膜来源的贴壁细胞治疗辐射损伤
CN102676451B (zh) *	2011-09-05	2014-04-16	博雅干细胞科技有限公司	从胎盘中分离间充质干细胞的方法
WO2013055476A1 (en)	2011-09-09	2013-04-18	Anthrogenesis Corporation	Treatment of amyotrophic lateral sclerosis using placental stem cells
US20140242038A1 (en) *	2011-10-11	2014-08-28	The Trustees Of Columbia University In The City Of New York	Method for generating beta cells
US20140341863A1 (en) *	2011-11-01	2014-11-20	Neostem, Inc.	Adult mesenchymal stem cell (msc) compositions and methods for preparing the same
US9611513B2 (en)	2011-12-23	2017-04-04	DePuy Synthes Products, Inc.	Detection of human umbilical cord tissue derived cells
US11311367B2 (en)	2012-01-31	2022-04-26	Wake Forest University Health Sciences	Tissue-engineered gut-sphincter complexes and methods of making the same
US9575054B2 (en)	2012-02-23	2017-02-21	Anthrogenesis Corporation	Identification of antitumor compounds using placenta
JP2015509508A (ja) *	2012-03-06	2015-03-30	エスシーティアンドビーインコーポレイテッド	胎盤性幹細胞、それを単離するための方法およびその使用
KR101422559B1 (ko) *	2012-03-09	2014-07-24	창원대학교 산학협력단	지방유래 줄기세포 배양액, 이의 제조방법, 및 이를 포함하는 발모촉진용 조성물
KR101523040B1 (ko) *	2012-06-26	2015-05-26	라정찬	고농도의 줄기세포 제조방법
US9657290B2 (en)	2012-07-03	2017-05-23	The Board Of Trustees Of The Leland Stanford Junior University	Scalable bio-element analysis
WO2014028453A2 (en)	2012-08-13	2014-02-20	Anthrogenesis Corporation	Natural killer cells and uses thereof
KR101532556B1 (ko) *	2012-09-03	2015-06-30	메디포스트(주)	간엽줄기세포의 배양 방법
CN104769101A (zh)	2012-09-04	2015-07-08	人类起源公司	组织产生方法
DK2892996T3 (da) *	2012-09-07	2019-10-07	Biolamina Ab	Stamcellebank
JP2015536326A (ja)	2012-10-19	2015-12-21	アントフロゲネシスコーポレーション	羊膜由来接着細胞を利用する疼痛の治療
EP2925307B1 (en)	2012-11-30	2020-10-28	McCord, Darlene E.	Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition
EP3838280A1 (en)	2012-12-07	2021-06-23	Celularity Inc.	Treating oral lesions using placental extracellular matrix
AU2013359076A1 (en) *	2012-12-14	2015-07-02	Anthrogenesis Corporation	Anoikis resistant placental stem cells and uses thereof
AU2013204922B2 (en)	2012-12-20	2015-05-14	Celgene Corporation	Chimeric antigen receptors
CN105142651A (zh)	2013-02-05	2015-12-09	人类起源公司	来自胎盘的自然杀伤细胞
KR101654970B1 (ko) *	2013-02-20	2016-09-06	사회복지법인 삼성생명공익재단	줄기세포를 유효성분으로 포함하는 뇌 염증성 질환의 치료용 조성물
JP2016512433A (ja)	2013-03-14	2016-04-28	アントフロゲネシスコーポレーション	増強胎盤幹細胞及びその使用
EP2968420B1 (en) *	2013-03-14	2018-09-05	Celularity, Inc.	Use of placental stem cells in treatment of acute kidney injury
EP2968418B1 (en) *	2013-03-15	2023-11-29	Nutech Medical, Inc.	Preparations derived from placental materials of making and using same
NO2975611T3 (pt)	2013-03-15	2018-06-09
US9862924B2 (en)	2013-03-15	2018-01-09	Wake Forest University Health Sciences	Neural progenitor cell differentiation
EP3831840A1 (en)	2013-03-15	2021-06-09	Celgene Corporation	Modified t lymphocytes
US9795639B1 (en)	2013-03-16	2017-10-24	BioDlogics, LLC	Methods for the treatment of erectile dysfunction by human birth tissue material compostion
CN103173405B (zh) *	2013-03-21	2017-11-07	北京京蒙高科干细胞技术有限公司	一种人胎盘成肌纤维母细胞的简易分离及鉴定方法
KR101583569B1 (ko) *	2013-05-15	2016-01-08	라정찬	정맥 투여용 줄기세포 조성물
EP3862422A1 (en)	2013-06-24	2021-08-11	Celularity Inc.	Extracellular matrix composition beads for cell culture
EP3068432A4 (en)	2013-11-15	2017-04-19	Anthrogenesis Corporation	Compositions comprising human placental perfusate cells, subpopulations thereof, and their uses
JP6486948B2 (ja) *	2014-01-08	2019-03-20	サムスンライフパブリックウェルフェアファウンデーション	純粋栄養膜層から由来した幹細胞及びそれを含む細胞治療剤
ES2858648T3 (es) *	2014-01-08	2021-09-30	Samsung Life Public Welfare Foundation	Células madre derivadas de la porción basal de la capa de trofoblastos coriónicos y terapia celular que comprende las mismas
CN103756965B (zh) *	2014-01-27	2016-04-06	山东省齐鲁干细胞工程有限公司	一种从胎盘中灌洗造血干细胞的方法
US20170042944A1 (en) *	2014-04-21	2017-02-16	Anthrogenesis Corporation	Treatment of conditions and complications in infants
EP3750993B1 (en)	2014-07-11	2023-12-27	Celgene Corporation	Methods of improving vector transduction efficiency into t lymphocytes
US20180080008A1 (en)	2014-08-12	2018-03-22	Anthrogenesis Corporation	Car-t lymphocytes engineered to home to lymph node b cell zone, skin, or gastrointestinal tract
DK3204022T3 (da)	2014-10-09	2021-03-08	Celularity Inc	Placenta-afledte adhærente celle-exosomer og anvendelser deraf
EP3214171A4 (en) *	2014-10-29	2018-07-11	Sungkwang Medical Foundation	Placenta-derived cells excreting c3 or c1r complement and composition containing same
CN107532333A (zh)	2015-02-22	2018-01-02	里兰斯坦福初级大学理事会	微筛选装置、方法和产品
WO2016149492A1 (en) *	2015-03-18	2016-09-22	Anthrogenesis Corporation	Methods of banking placental tissue and cells
WO2016187413A1 (en)	2015-05-21	2016-11-24	Musculoskeletal Transplant Foundation	Modified demineralized cortical bone fibers
NZ737474A (en) *	2015-05-28	2022-11-25	Celularity Inc	Placental-derived stem cells to restore the regenerative engine, correct proteomic defects and extend lifespan
WO2017039251A1 (ko) *	2015-08-28	2017-03-09	주식회사 차바이오텍	향상된 산후 부착형 세포 및 그의 용도
CA2998759A1 (en)	2015-09-15	2017-03-23	Celularity Inc.	Treatment of diabetic peripheral neuropathy using placental cells
MX2018004005A (es) *	2015-09-29	2018-06-12	Celularity Inc	Ensayo de potencia celular.
US20190015190A1 (en)	2015-12-30	2019-01-17	Wake Forest University Health Sciences	Tissue-engineered gut-sphincter complexes and methods of making the same
EP3429360A4 (en) *	2016-03-16	2019-08-28	Cell Medicine, Inc.	MESENCHYMAL STEM CELLS WITH IMPROVED EFFICACY
EP3516392A4 (en) *	2016-09-19	2020-05-20	The Board of Trustees of the Leland Stanford Junior University	MICROSCREEN AND SORTING DEVICE, METHOD AND PRODUCTS
AU2017354272A1 (en) *	2016-11-03	2019-05-23	Exostem Biotec Ltd.	Mesenchymal stem cells populations, their products, and use thereof
EP3538277B1 (en)	2016-11-14	2024-05-29	Orca Biosystems, Inc.	Apparatuses for sorting target particles
CA3046078A1 (en)	2016-12-05	2018-06-14	Celularity Inc.	Treatment of lymphedema and related conditions using placental adherent cells
US10433112B2 (en) *	2017-02-22	2019-10-01	Middle Chart, LLC	Methods and apparatus for orienteering
CA3056406A1 (en)	2017-03-15	2018-09-20	Orca Biosystems Inc.	Compositions and methods for hematopoietic stem cell transplants
JP7102397B2 (ja) *	2017-04-03	2022-07-19	株式会社カネカ	間葉系幹細胞を含む細胞集団とその製造方法、及び医薬組成物
CN107586757A (zh) *	2017-11-01	2018-01-16	天津昂赛细胞基因工程有限公司	一种猪间充质干细胞培养液及其制备方法
US10142452B1 (en) *	2018-05-29	2018-11-27	Guangzhou Zhijing Technology Co., Ltd	Mobile terminal unlock method
US20230028680A1 (en)	2018-11-30	2023-01-26	Celularity Inc.	Expansion of natural killer cells and ilc3 cells with novel aromatic compounds
KR20210143721A (ko) *	2019-03-27	2021-11-29	플루리스템 리미티드	미적 및 화장 치료 및 모발 성장의 자극을 위한 방법 및 조성물
CN109908351B (zh) *	2019-04-08	2021-04-06	中南大学	circ_ADARB1在制备鼻咽癌治疗制剂中的应用和治疗制剂
US20220265712A1 (en)	2019-06-14	2022-08-25	Celularity Inc.	Populations of natural killer cells for treating cancers
WO2021003254A1 (en) *	2019-07-01	2021-01-07	Auxocell Laboratories, Inc.	Cryopreservation medium comprising a tissue extract
CN110468099B (zh) *	2019-07-19	2023-08-15	海门生原干细胞科技有限公司	一种骨髓间充质干细胞培养基及其应用
US20220273716A1 (en)	2019-07-25	2022-09-01	Celularity Inc.	Populations of natural killer cells comprising a cd38 chimeric antigen receptor
WO2021022229A1 (en)	2019-07-31	2021-02-04	Celularity Inc.	Populations of natural killer cells comprising a cleavage resistant cd16
CN110592005A (zh) *	2019-08-14	2019-12-20	广州乾晖生物科技有限公司	间充质干细胞的分离方法
WO2021113849A1 (en)	2019-12-05	2021-06-10	Celularity Inc.	Her2+ cancer treatment with populations of natural killer cells comprising a cleavage resistant cd16
US20220000919A1 (en)	2020-01-29	2022-01-06	Celularity Inc.	Placental derived natural killer cells for treatment of coronavirus infections
US20230210909A1 (en)	2020-05-08	2023-07-06	Celularity Inc.	Placenta-derived adherent (pda) stem cell for the treatment of adults with sars-cov-2 related acute respiratory failure and ards (covid-19)
CN111793598A (zh) *	2020-05-28	2020-10-20	深圳华大基因细胞科技有限责任公司	一种从胎盘中获取母体来源间充质干细胞的方法
WO2021257073A1 (en) *	2020-06-17	2021-12-23	Joy Kong	Method for producing mesenchymal stem cells from neonatal stem cells
CN111956787A (zh) *	2020-07-06	2020-11-20	沃森克里克（北京）生物科技有限公司	一种毛发增长剂和育毛剂及其应用
WO2022120382A1 (en) *	2020-12-03	2022-06-09	42Bio, Inc.	Regenerative tissue extract from non-human mammalian placenta
CN112592885B (zh) *	2020-12-23	2022-06-17	山东华领奥源生物科技有限公司	一种胎盘亚全能干细胞的分离培养方法
WO2023278628A1 (en)	2021-06-29	2023-01-05	Celularity Inc.	Human placental hematopoietic stem cell derived natural killer cells in acute myeloid leukemia (aml) remission with minimal residual disease (mrd) or relapsed/refractory aml
WO2023010123A1 (en)	2021-07-29	2023-02-02	Celularity Inc.	Placenta-dervied nk cells as a senolytic for therapeutic and other uses
WO2023137344A1 (en)	2022-01-11	2023-07-20	Celularity Inc.	Cleavage resistant cd16 constructs and uses thereof
CN115478111B (zh) *	2022-06-07	2024-07-05	兰州大学	一种与绵羊免疫性状相关的分子标记、其检测方法和应用
CN116144583B (zh) *	2023-04-19	2023-08-25	北京雪颜博润生物科技有限公司	一种获取人胎盘胚源干细胞的方法及应用

Family Cites Families (336)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3862002A (en)	1962-05-08	1975-01-21	Sanfar Lab Inc	Production of physiologically active placental substances
GB1144602A (en)	1965-04-27	1969-03-05	Sven Axel Tell	Improvements in or relating to dynamometers
US4829000A (en)	1985-08-30	1989-05-09	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Reconstituted basement membrane complex with biological activity
US4798824A (en)	1985-10-03	1989-01-17	Wisconsin Alumni Research Foundation	Perfusate for the preservation of organs
US5902741A (en)	1986-04-18	1999-05-11	Advanced Tissue Sciences, Inc.	Three-dimensional cartilage cultures
US5863531A (en)	1986-04-18	1999-01-26	Advanced Tissue Sciences, Inc.	In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5266480A (en)	1986-04-18	1993-11-30	Advanced Tissue Sciences, Inc.	Three-dimensional skin culture system
US5744347A (en)	1987-01-16	1998-04-28	Ohio University Edison Biotechnology Institute	Yolk sac stem cells and their uses
NZ226750A (en)	1987-10-29	1990-09-26	Amrad Corp Ltd	Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene
US5004681B1 (en) *	1987-11-12	2000-04-11	Biocyte Corp	Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US5192553A (en)	1987-11-12	1993-03-09	Biocyte Corporation	Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
GB8803697D0 (en)	1988-02-17	1988-03-16	Deltanine Research Ltd	Clinical developments using amniotic membrane cells
US5284766A (en)	1989-02-10	1994-02-08	Kao Corporation	Bed material for cell culture
FR2646438B1 (fr)	1989-03-20	2007-11-02	Pasteur Institut	Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
US5437994A (en)	1989-06-15	1995-08-01	Regents Of The University Of Michigan	Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5605822A (en) *	1989-06-15	1997-02-25	The Regents Of The University Of Michigan	Methods, compositions and devices for growing human hematopoietic cells
US5635386A (en)	1989-06-15	1997-06-03	The Regents Of The University Of Michigan	Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
US5763266A (en)	1989-06-15	1998-06-09	The Regents Of The University Of Michigan	Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
US5399493A (en)	1989-06-15	1995-03-21	The Regents Of The University Of Michigan	Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
DE69033493D1 (de)	1989-07-25	2004-08-12	Cell Genesys Inc	Homologe rekombination für universelle donorzellen und chimerische säugetierzellen
US5464764A (en)	1989-08-22	1995-11-07	University Of Utah Research Foundation	Positive-negative selection methods and vectors
KR100233781B1 (ko)	1989-11-06	1999-12-01	스테펜 에이. 쉐어윈	동종 재조합을 이용하는 단백질 제조방법
US5272071A (en)	1989-12-22	1993-12-21	Applied Research Systems Ars Holding N.V.	Method for the modification of the expression characteristics of an endogenous gene of a given cell line
US5061620A (en)	1990-03-30	1991-10-29	Systemix, Inc.	Human hematopoietic stem cell
US5635387A (en)	1990-04-23	1997-06-03	Cellpro, Inc.	Methods and device for culturing human hematopoietic cells and their precursors
US6326198B1 (en)	1990-06-14	2001-12-04	Regents Of The University Of Michigan	Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US6010696A (en)	1990-11-16	2000-01-04	Osiris Therapeutics, Inc.	Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5733542A (en) *	1990-11-16	1998-03-31	Haynesworth; Stephen E.	Enhancing bone marrow engraftment using MSCS
US5226914A (en)	1990-11-16	1993-07-13	Caplan Arnold I	Method for treating connective tissue disorders
US5486359A (en) *	1990-11-16	1996-01-23	Osiris Therapeutics, Inc.	Human mesenchymal stem cells
US5811094A (en)	1990-11-16	1998-09-22	Osiris Therapeutics, Inc.	Connective tissue regeneration using human mesenchymal stem cell preparations
US5197985A (en)	1990-11-16	1993-03-30	Caplan Arnold I	Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
US5837539A (en)	1990-11-16	1998-11-17	Osiris Therapeutics, Inc.	Monoclonal antibodies for human mesenchymal stem cells
US5190556A (en)	1991-03-19	1993-03-02	O.B. Tech, Inc.	Cord cutter sampler
US5744361A (en) *	1991-04-09	1998-04-28	Indiana University	Expansion of human hematopoietic progenitor cells in a liquid medium
US5750376A (en)	1991-07-08	1998-05-12	Neurospheres Holdings Ltd.	In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
EP0552380A4 (en)	1991-08-08	1995-01-25	Kao Corp	Cell culture support, production thereof, and production of cell cluster using same
EP0529751A1 (en)	1991-08-09	1993-03-03	W.R. Grace & Co.-Conn.	Cell culture substrate, test material for cell culture and preparations thereof
AU2515992A (en)	1991-08-20	1993-03-16	Genpharm International, Inc.	Gene targeting in animal cells using isogenic dna constructs
US5356373A (en)	1991-11-15	1994-10-18	Miles Inc.	Method and apparatus for autologous transfusions in premature infants
EP0627003A1 (en)	1991-12-23	1994-12-07	British Bio-Technology Limited	Stem cell inhibiting proteins
EP0590156A4 (en)	1992-03-31	1994-07-13	Toray Industries	Novel, physiologically active protein and hemopoietic stem cell growth promoter
US5460964A (en)	1992-04-03	1995-10-24	Regents Of The University Of Minnesota	Method for culturing hematopoietic cells
US5552267A (en)	1992-04-03	1996-09-03	The Trustees Of Columbia University In The City Of New York	Solution for prolonged organ preservation
AU4543193A (en)	1992-06-22	1994-01-24	Henry E. Young	Scar inhibitory factor and use thereof
US5693482A (en)	1992-07-27	1997-12-02	California Institute Of Technology	Neural chest stem cell assay
US5672346A (en)	1992-07-27	1997-09-30	Indiana University Foundation	Human stem cell compositions and methods
US5849553A (en)	1992-07-27	1998-12-15	California Institute Of Technology	Mammalian multipotent neural stem cells
WO1994011493A1 (en)	1992-11-16	1994-05-26	Applied Immune Sciences, Inc.	Pluripotential quiescent stem cell population
US5772992A (en)	1992-11-24	1998-06-30	G.D. Searle & Co.	Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
US5654186A (en)	1993-02-26	1997-08-05	The Picower Institute For Medical Research	Blood-borne mesenchymal cells
DE69431473T2 (de) *	1993-03-31	2003-08-07	Pro-Neuron, Inc.	Inhibitor der stammzellproliferation und seine verwendung
GB9308271D0 (en)	1993-04-21	1993-06-02	Univ Edinburgh	Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
US5709854A (en)	1993-04-30	1998-01-20	Massachusetts Institute Of Technology	Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5372581A (en)	1993-07-21	1994-12-13	Minneapolis Children's Services Corporation	Method and apparatus for placental blood collection
IL107483A0 (en)	1993-11-03	1994-02-27	Yeda Res & Dev	Bone marrow transplantation
US5591625A (en) *	1993-11-24	1997-01-07	Case Western Reserve University	Transduced mesenchymal stem cells
US6288030B1 (en)	1993-12-22	2001-09-11	Amgen Inc.	Stem cell factor formulations and methods
US6001654A (en)	1994-01-28	1999-12-14	California Institute Of Technology	Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors
US5942496A (en)	1994-02-18	1999-08-24	The Regent Of The University Of Michigan	Methods and compositions for multiple gene transfer into bone cells
US5580724A (en)	1994-03-25	1996-12-03	Board Of Regents, The University Of Texas System	Differential expansion of fetal stem cells in maternal circulation for use in prenatal genetic analysis
AU686823B2 (en)	1994-06-06	1998-02-12	Case Western Reserve University	Biomatrix for tissue regeneration
US6174333B1 (en)	1994-06-06	2001-01-16	Osiris Therapeutics, Inc.	Biomatrix for soft tissue regeneration using mesenchymal stem cells
DE4422667A1 (de)	1994-06-30	1996-01-04	Boehringer Ingelheim Int	Verfahren zur Herstellung und Züchtung hämatopoetischer Vorläuferzellen
US6103522A (en) *	1994-07-20	2000-08-15	Fred Hutchinson Cancer Research Center	Human marrow stromal cell lines which sustain hematopoiesis
US5516532A (en)	1994-08-05	1996-05-14	Children's Medical Center Corporation	Injectable non-immunogenic cartilage and bone preparation
US5840502A (en)	1994-08-31	1998-11-24	Activated Cell Therapy, Inc.	Methods for enriching specific cell-types by density gradient centrifugation
US5827742A (en)	1994-09-01	1998-10-27	Beth Israel Deaconess Medical Center, Inc.	Method of selecting pluripotent hematopioetic progenitor cells
US5665557A (en)	1994-11-14	1997-09-09	Systemix, Inc.	Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof
US5874301A (en)	1994-11-21	1999-02-23	National Jewish Center For Immunology And Respiratory Medicine	Embryonic cell populations and methods to isolate such populations
US5914268A (en)	1994-11-21	1999-06-22	National Jewish Center For Immunology & Respiratory Medicine	Embryonic cell populations and methods to isolate such populations
US5789147A (en)	1994-12-05	1998-08-04	New York Blood Center, Inc.	Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood
US5736396A (en) *	1995-01-24	1998-04-07	Case Western Reserve University	Lineage-directed induction of human mesenchymal stem cell differentiation
US7410773B2 (en)	1995-02-02	2008-08-12	Ghazi Jaswinder Dhoot	Method of preparing an undifferentiated cell
US5695998A (en)	1995-02-10	1997-12-09	Purdue Research Foundation	Submucosa as a growth substrate for islet cells
US6011000A (en)	1995-03-03	2000-01-04	Perrine; Susan P.	Compositions for the treatment of blood disorders
US5906934A (en) *	1995-03-14	1999-05-25	Morphogen Pharmaceuticals, Inc.	Mesenchymal stem cells for cartilage repair
US5716616A (en) *	1995-03-28	1998-02-10	Thomas Jefferson University	Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects
US6974571B2 (en)	1995-03-28	2005-12-13	Thomas Jefferson University	Isolated stromal cells and methods of using the same
US5733541A (en) *	1995-04-21	1998-03-31	The Regent Of The University Of Michigan	Hematopoietic cells: compositions and methods
US5677139A (en)	1995-04-21	1997-10-14	President And Fellows Of Harvard College	In vitro differentiation of CD34+ progenitor cells into T lymphocytes
WO1996034035A1 (en)	1995-04-27	1996-10-31	The Procter & Gamble Company	Carrier substrate treated with high internal water phase inverse emulsion made with an organopolysiloxane-polyoxyalkylene emulsifier
US5925567A (en)	1995-05-19	1999-07-20	T. Breeders, Inc.	Selective expansion of target cell populations
US5908782A (en)	1995-06-05	1999-06-01	Osiris Therapeutics, Inc.	Chemically defined medium for human mesenchymal stem cells
US5830708A (en)	1995-06-06	1998-11-03	Advanced Tissue Sciences, Inc.	Methods for production of a naturally secreted extracellular matrix
AU6223296A (en)	1995-06-07	1996-12-30	Novartis Ag	Methods for obtaining compositions enriched for hematopoieti c stem cells and antibodies for use therein
US6306575B1 (en)	1995-06-16	2001-10-23	Stemcell Technologies, Inc.	Methods for preparing enriched human hematopoietic cell preparations
US5654381A (en)	1995-06-16	1997-08-05	Massachusetts Institute Of Technology	Functionalized polyester graft copolymers
US5877299A (en) *	1995-06-16	1999-03-02	Stemcell Technologies Inc.	Methods for preparing enriched human hematopoietic cell preparations
US5935576A (en)	1995-09-13	1999-08-10	Fordham University	Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US5800539A (en)	1995-11-08	1998-09-01	Emory University	Method of allogeneic hematopoietic stem cell transplantation without graft failure or graft vs. host disease
US5858782A (en) *	1995-11-13	1999-01-12	Regents Of The University Of Michigan	Functional human hematopoietic cells
US5922597A (en)	1995-11-14	1999-07-13	Regents Of The University Of Minnesota	Ex vivo culture of stem cells
DE69634303T2 (de)	1995-11-16	2006-01-05	Case Western Reserve University, Cleveland	Chondrogene in vitro induktion von menschlichen mensenchymalen stammzellen
DE69635899T2 (de)	1995-11-17	2006-11-23	Asahi Kasei Kabushiki Kaisha	Polypeptid, das die differenzierung unterdrueckt
US5716794A (en) *	1996-03-29	1998-02-10	Xybernaut Corporation	Celiac antigen
JP2000508911A (ja) *	1996-04-19	2000-07-18	オシリスセラピューティクス，インコーポレイテッド	間葉幹細胞を用いる骨の再生および増強
AU2808397A (en)	1996-04-26	1997-11-19	Case Western Reserve University	Skin regeneration using mesenchymal stem cells
US6455678B1 (en)	1996-04-26	2002-09-24	Amcell Corporation	Human hematopoietic stem and progenitor cell antigen
US5919176A (en)	1996-05-14	1999-07-06	Children's Hospital Medical Center Of Northern California	Apparatus and method for collecting blood from an umbilical cord
US5827740A (en)	1996-07-30	1998-10-27	Osiris Therapeutics, Inc.	Adipogenic differentiation of human mesenchymal stem cells
US6358737B1 (en)	1996-07-31	2002-03-19	Board Of Regents, The University Of Texas System	Osteocyte cell lines
US5851984A (en)	1996-08-16	1998-12-22	Genentech, Inc.	Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
US5916202A (en)	1996-08-30	1999-06-29	Haswell; John N.	Umbilical cord blood collection
US6227202B1 (en)	1996-09-03	2001-05-08	Maulana Azad Medical College	Method of organogenesis and tissue regeneration/repair using surgical techniques
US5945337A (en)	1996-10-18	1999-08-31	Quality Biological, Inc.	Method for culturing CD34+ cells in a serum-free medium
US5919702A (en)	1996-10-23	1999-07-06	Advanced Tissue Science, Inc.	Production of cartilage tissue using cells isolated from Wharton's jelly
US5969105A (en)	1996-10-25	1999-10-19	Feng; Yiqing	Stem cell factor receptor agonists
US6335195B1 (en) *	1997-01-28	2002-01-01	Maret Corporation	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
US6152142A (en)	1997-02-28	2000-11-28	Tseng; Scheffer C. G.	Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
US6231880B1 (en)	1997-05-30	2001-05-15	Susan P. Perrine	Compositions and administration of compositions for the treatment of blood disorders
DK1028737T3 (da)	1997-07-03	2007-08-13	Osiris Therapeutics Inc	Humane mesenchymale stamceller fra perifert blod
US7514074B2 (en)	1997-07-14	2009-04-07	Osiris Therapeutics, Inc.	Cardiac muscle regeneration using mesenchymal stem cells
EP1007631B2 (en)	1997-07-14	2009-02-18	Osiris Therapeutics, Inc.	Cardiac muscle regeneration using mesenchymal stem cells
US6077708A (en)	1997-07-18	2000-06-20	Collins; Paul C.	Method of determining progenitor cell content of a hematopoietic cell culture
US5879318A (en) *	1997-08-18	1999-03-09	Npbi International B.V.	Method of and closed system for collecting and processing umbilical cord blood
AU9127098A (en)	1997-09-04	1999-03-22	Osiris Therapeutics, Inc.	Ligands that modulate differentiation of mesenchymal stem cells
US5968829A (en)	1997-09-05	1999-10-19	Cytotherapeutics, Inc.	Human CNS neural stem cells
US6093531A (en)	1997-09-29	2000-07-25	Neurospheres Holdings Ltd.	Generation of hematopoietic cells from multipotent neural stem cells
WO1999020741A1 (en)	1997-10-23	1999-04-29	Geron Corporation	Methods and materials for the growth of primate-derived primordial stem cells
US6248587B1 (en)	1997-11-26	2001-06-19	University Of Southern Cailfornia	Method for promoting mesenchymal stem and lineage-specific cell proliferation
US6059968A (en)	1998-01-20	2000-05-09	Baxter International Inc.	Systems for processing and storing placenta/umbilical cord blood
US6291240B1 (en)	1998-01-29	2001-09-18	Advanced Tissue Sciences, Inc.	Cells or tissues with increased protein factors and methods of making and using same
CA2323073C (en) *	1998-03-13	2010-06-22	Osiris Therapeutics, Inc.	Uses for human non-autologous mesenchymal stem cells
ES2258329T3 (es)	1998-03-18	2006-08-16	Osiris Therapeutics, Inc.	Celulas madre mesenquimaticas para la prevencion y tratamiento de respuestas inmunes en trasplantes.
US6368636B1 (en)	1998-03-18	2002-04-09	Osiris Therapeutics, Inc.	Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
AU2999199A (en)	1998-04-03	1999-10-25	Osiris Therapeutics, Inc.	Mesenchymal stem cells as immunosuppressants
MY132924A (en)	1998-05-04	2007-10-31	Point Therapeutics Inc	Hematopoietic stimulation
ES2246085T3 (es)	1998-05-07	2006-02-01	University Of South Florida	Celulas de medula osea como fuente de neuronas util para reparar la medula espinal y el cerebro.
US6835377B2 (en)	1998-05-13	2004-12-28	Osiris Therapeutics, Inc.	Osteoarthritis cartilage regeneration
CA2328425A1 (en)	1998-05-22	1999-12-02	Osiris Therapeutics, Inc.	Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells
ES2292245T3 (es)	1998-05-29	2008-03-01	Osiris Therapeutics, Inc.	Celulas madre mesenquimaticas cd45+ y/o fibroblasto+humanas.
EP1108011A2 (en)	1998-06-08	2001-06-20	Osiris Therapeutics, Inc.	In vitro maintenance of hematopoietic stem cells
ES2296413T3 (es)	1998-06-08	2008-04-16	Osiris Therapeutics, Inc.	Regulacion de la diferenciacion de celulas madre hematopoyeticas por el uso de celulas madre mesenquimaticas humanas.
US6713245B2 (en)	1998-07-06	2004-03-30	Diacrin, Inc.	Methods for storing neural cells such that they are suitable for transplantation
EP1100488B1 (en) *	1998-07-28	2003-04-23	SYNTHES AG Chur	Use of creatine compounds for treatment of bone or cartilage cells and tissues
US5958767A (en)	1998-08-14	1999-09-28	The Children's Medical Center Corp.	Engraftable human neural stem cells
JP3517359B2 (ja)	1998-09-14	2004-04-12	テルモ株式会社	細胞分離・回収装置および細胞の分離・回収方法
WO2000017325A1 (en)	1998-09-23	2000-03-30	Mount Sinai Hospital	Trophoblast cell preparations
US6875607B1 (en)	1998-11-09	2005-04-05	Es Cell International Pte Ltd	Embryonic stem cells
US6548299B1 (en)	1999-11-12	2003-04-15	Mark J. Pykett	Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
JP2002529073A (ja)	1998-11-12	2002-09-10	セルサイエンスセラピューティックスインコーポレーテッド	三次元装置における造血前駆細胞からのリンパ様組織特異的細胞の生成
US6184035B1 (en)	1998-11-18	2001-02-06	California Institute Of Technology	Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells
US6102871A (en)	1998-11-23	2000-08-15	Coe; Rosemarie O.	Blood collection funnel
US6328765B1 (en)	1998-12-03	2001-12-11	Gore Enterprise Holdings, Inc.	Methods and articles for regenerating living tissue
DE69919029T2 (de)	1998-12-24	2005-09-08	Biosafe S.A.	Vorrichtung zur bluttrennung, insbesondere zur konzentrierung von hematopoietischen stammzellen
EP2208782B1 (en)	1999-02-04	2017-05-31	Pluristem Ltd.	Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
US20030007954A1 (en) *	1999-04-12	2003-01-09	Gail K. Naughton	Methods for using a three-dimensional stromal tissue to promote angiogenesis
KR100696407B1 (ko)	1999-04-16	2007-03-19	더블유엠. 마쉬 라이스 유니버시티	폴리(프로필렌 푸마레이트)-디아크릴레이트 마크로머와가교결합된 생분해성 폴리(프로필렌 푸마레이트) 네트워크
IN191359B (pt)	1999-04-20	2003-11-29	Nat Inst Immunology
WO2000073421A2 (en)	1999-06-02	2000-12-07	Lifebank Services, L.L.C.	Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells
US6355699B1 (en)	1999-06-30	2002-03-12	Ethicon, Inc.	Process for manufacturing biomedical foams
US6333029B1 (en) *	1999-06-30	2001-12-25	Ethicon, Inc.	Porous tissue scaffoldings for the repair of regeneration of tissue
US8147824B2 (en)	1999-08-05	2012-04-03	Athersys, Inc.	Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US7015037B1 (en)	1999-08-05	2006-03-21	Regents Of The University Of Minnesota	Multiponent adult stem cells and methods for isolation
US8075881B2 (en) *	1999-08-05	2011-12-13	Regents Of The University Of Minnesota	Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
CA2852534A1 (en)	1999-08-05	2001-02-15	Abt Holding Company	Multipotent adult stem cells and methods for isolation
US6239157B1 (en)	1999-09-10	2001-05-29	Osiris Therapeutics, Inc.	Inhibition of osteoclastogenesis
EP1218489B1 (en)	1999-09-24	2009-03-18	Cybios LLC	Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US6685936B2 (en)	1999-10-12	2004-02-03	Osiris Therapeutics, Inc.	Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation
US6280718B1 (en)	1999-11-08	2001-08-28	Wisconsin Alumni Reasearch Foundation	Hematopoietic differentiation of human pluripotent embryonic stem cells
DE19954421A1 (de)	1999-11-12	2001-05-31	Lohmann Therapie Syst Lts	Filmförmige Zubereitung zur biphasigen Freisetzung pharmakologisch wirksamer oder anderer Substanzen
JP2003530826A (ja)	1999-11-17	2003-10-21	ユニバーシティーオブロチェスター	ヒトのエキソビボ免疫系
US7455983B2 (en)	2000-01-11	2008-11-25	Geron Corporation	Medium for growing human embryonic stem cells
AU2001243464B2 (en)	2000-03-09	2006-04-13	Saneron Ccel Therapeutics, Inc.	Human cord blood as a source of neural tissue for repair of the brain and spinal cord
DK1264877T3 (da)	2000-03-16	2013-10-28	Cellseed Inc	Celledyrkningsbæremateriale, fremgangsmåde til samdyrkning af celler og samdyrket cellelag opnået derved
US20010038836A1 (en)	2000-04-04	2001-11-08	Matthew During	Application of myeloid-origin cells to the nervous system
ATE332708T1 (de)	2000-06-06	2006-08-15	Glaxo Group Ltd	Krebsbehandlung zusammensetzung, welche ein antineoplastisches mittel und pde4 inhibitor enthält
US20050009876A1 (en)	2000-07-31	2005-01-13	Bhagwat Shripad S.	Indazole compounds, compositions thereof and methods of treatment therewith
US7560280B2 (en)	2000-11-03	2009-07-14	Kourion Therapeutics Gmbh	Human cord blood derived unrestricted somatic stem cells (USSC)
GB2386125B (en)	2000-11-22	2005-02-23	Geron Corp	Tolerizing allografts of pluripotent stem cells
DK1349918T3 (da) *	2000-12-06	2014-11-10	Anthrogenesis Corp	Fremgangsmåde til indsamling af stamceller fra moderkagen
US7311905B2 (en)	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US20080152629A1 (en)	2000-12-06	2008-06-26	James Edinger	Placental stem cell populations
US20030045552A1 (en) *	2000-12-27	2003-03-06	Robarge Michael J.	Isoindole-imide compounds, compositions, and uses thereof
US7091353B2 (en)	2000-12-27	2006-08-15	Celgene Corporation	Isoindole-imide compounds, compositions, and uses thereof
KR101132545B1 (ko)	2001-02-14	2012-04-02	안트로제네시스 코포레이션	산후 포유류의 태반, 이의 용도 및 태반 줄기세포
CA3046566A1 (en) *	2001-02-14	2002-08-22	Anthrogenesis Corporation	Post-partum mammalian placental stem cells for use in the treatment of neurological or renal diseases and disorders
JP2004529621A (ja)	2001-02-14	2004-09-30	ティーファークト，レオ	多能性成体幹細胞、その起源、それを得る方法および維持する方法、それを分化させる方法、その使用法、ならびにそれ由来の細胞
US20020132343A1 (en)	2001-03-19	2002-09-19	Clark Lum	System and method for delivering umbilical cord-derived tissue-matched stem cells for transplantation
US20030044977A1 (en) *	2001-08-10	2003-03-06	Norio Sakuragawa	Human stem cells originated from human amniotic mesenchymal cell layer
DE10139783C1 (de)	2001-08-14	2003-04-17	Transtissue Technologies Gmbh	Zellzusammensetzungen zur Behandlung von Osteoarthrose, sowie Verfahren zu deren Herstellung
WO2003018780A1 (en)	2001-08-27	2003-03-06	Advanced Cell Technology, Inc.	De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
EP1288293A1 (en)	2001-08-30	2003-03-05	Norio Sakuragawa	Human neural stem cells originated from human amniotic mesenchymal cell layer
CN1195055C (zh) *	2001-09-06	2005-03-30	周胜利	从胎盘组织中提取造血干细胞用于建立造血干细胞库的新方法
US9969980B2 (en)	2001-09-21	2018-05-15	Garnet Biotherapeutics	Cell populations which co-express CD49c and CD90
WO2003040346A2 (en)	2001-11-09	2003-05-15	Artecel Sciences, Inc.	Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
EP1442115B9 (en)	2001-11-15	2009-12-16	Children's Medical Center Corporation	Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
JP3728750B2 (ja)	2001-11-22	2005-12-21	ニプロ株式会社	培養皮膚及びその製造方法
US7799324B2 (en)	2001-12-07	2010-09-21	Geron Corporation	Using undifferentiated embryonic stem cells to control the immune system
JP3934539B2 (ja)	2001-12-12	2007-06-20	独立行政法人科学技術振興機構	胎盤等由来の成体又は生後組織の前駆細胞
WO2003055989A2 (en)	2001-12-21	2003-07-10	Mount Sinai Hospital	Cellular compositions and methods of making and using them
US20040018178A1 (en)	2002-01-22	2004-01-29	Advanced Cell Technology	Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis
KR101176146B1 (ko) *	2002-02-13	2012-08-22	안트로제네시스 코포레이션	산후 포유류 태반으로부터 유래한 배아-유사 줄기 세포와그 세포를 사용한 용도 및 치료방법
ATE365793T1 (de) *	2002-02-19	2007-07-15	Medipost Co Ltd	Verfahren zur isolierung und kulturexpansion mesenchymaler stamm-/vorläuferzellen aus nabelschnurblut sowie verfahren zur differenzierung von aus nabelschnurblut stammenden mesenchymalen stamm-/vorläuferzellen in unterschiedliche mesenchymgewebe
US20080299090A1 (en)	2002-02-25	2008-12-04	Kansas State University Research Foundation	Use Of Umbilical Cord Matrix Cells
US20030161818A1 (en)	2002-02-25	2003-08-28	Kansas State University Research Foundation	Cultures, products and methods using stem cells
US7736892B2 (en)	2002-02-25	2010-06-15	Kansas State University Research Foundation	Cultures, products and methods using umbilical cord matrix cells
IL164079A0 (en)	2002-03-15	2005-12-18	Us Dept Veterans Affairs	Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
US20030187515A1 (en)	2002-03-26	2003-10-02	Hariri Robert J.	Collagen biofabric and methods of preparing and using the collagen biofabric
JPWO2003080822A1 (ja) *	2002-03-27	2005-07-28	ニプロ株式会社	胎盤由来の間葉系細胞およびその医学的用途
US7498171B2 (en)	2002-04-12	2009-03-03	Anthrogenesis Corporation	Modulation of stem and progenitor cell differentiation, assays, and uses thereof
CA2481387A1 (en)	2002-04-12	2003-10-23	Celgene Corporation	Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
KR20050000400A (ko)	2002-04-12	2005-01-03	셀진 코포레이션	줄기 및 전구 세포 분화의 조절, 측정 및 이들의 용도
AU2003239159A1 (en)	2002-04-19	2003-11-03	University Of Pittsburgh Of The Commonwealth System Of Higher Education	Placental derived stem cells and uses thereof
US20040161419A1 (en)	2002-04-19	2004-08-19	Strom Stephen C.	Placental stem cells and uses thereof
US20050058641A1 (en)	2002-05-22	2005-03-17	Siemionow Maria Z.	Tolerance induction and maintenance in hematopoietic stem cell allografts
WO2003102151A2 (en)	2002-05-30	2003-12-11	Celgene Corporation	Modulating cell differentiation and treating myeloprolifertive disorders with jnk/mkk inhibitors
AU2003273574A1 (en)	2002-05-31	2003-12-19	Osiris Therapeutics, Inc.	Intraperitoneal delivery of genetically engineered mesenchymal stem cells
US7422736B2 (en)	2002-07-26	2008-09-09	Food Industry Research And Development Institute	Somatic pluripotent cells
EP1527161B1 (fr)	2002-07-31	2015-10-28	Yves Saint-Laurent Parfums	Cellules souches issues de tissu adipeux et cellules differenciees issues de ces cellules
US20060147424A1 (en)	2002-08-23	2006-07-06	Norio Sakuragawa	Human bone stem cells
KR100476790B1 (ko)	2002-09-13	2005-03-16	주식회사 제넨메드	세포 저장 용액과 이를 이용한 동물 세포의 동결 및 저장방법
US20040062753A1 (en)	2002-09-27	2004-04-01	Alireza Rezania	Composite scaffolds seeded with mammalian cells
EP1571910A4 (en) *	2002-11-26	2009-10-28	Anthrogenesis Corp	CYTOTHERAPEUTIC AGENTS, CYTOTHERAPEUTIC UNITS AND METHODS OF TREATMENT IN WHICH THEY INTERVENE
JP2004210713A (ja) *	2002-12-27	2004-07-29	Asahi Kasei Corp	医療用胎盤由来細胞製剤
CA2515469C (en)	2003-02-11	2013-12-17	John E. Davies	Progenitor cells from wharton's jelly of human umbilical cord
CA2515594A1 (en)	2003-02-13	2004-08-26	Anthrogenesis Corporation	Use of umbilical cord blood to treat individuals having a disease, disorder or condition
WO2004087896A2 (en)	2003-03-31	2004-10-14	Pfizer Products Inc.	Hepatocyte differentiation of stem cells
CN1548529A (zh)	2003-05-09	2004-11-24	中国人民解放军军事医学科学院基础医	一种人胎盘间充质干细胞的分离方法
US9579351B2 (en) *	2003-06-27	2017-02-28	DePuy Synthes Products, Inc.	Postpartum cells derived from placental tissue, and methods of making and using the same
US7875272B2 (en)	2003-06-27	2011-01-25	Ethicon, Incorporated	Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
WO2005017117A2 (en) *	2003-08-14	2005-02-24	Martin Haas	Multipotent amniotic fetal stem cells (mafsc) and banking of same
AR046123A1 (es)	2003-10-17	2005-11-23	Crc For Innovative Dairy Produ	Aislamiento de celulas simil-celulas madre, uso de las mismas
US20050089513A1 (en)	2003-10-28	2005-04-28	Norio Sakuragawa	Side population cells originated from human amnion and their uses
EP1682654A2 (en)	2003-11-10	2006-07-26	Amgen Inc.	Methods of using g-csf mobilized c-kit+cells in the production of embryoid body-like cell clusters for tissue repair and in the treatment of cardiac myopathy
KR100560340B1 (ko)	2003-11-11	2006-03-14	한훈	제대혈로부터 중간엽 줄기세포의 분리 및 배양 방법
JP2005151907A (ja)	2003-11-27	2005-06-16	Shigeo Saito	胎盤又は羊膜由来ヒト幹細胞及びその樹立方法並びに臓器への分化誘導方法
KR20110116225A (ko)	2003-12-02	2011-10-25	셀진 코포레이션	혈색소병증　및　빈혈의　치료　및　관리를　위한　방법및　조성물
TWI338714B (en)	2003-12-02	2011-03-11	Cathay General Hospital	Method of isolation and enrichment of mesenchymal stem cells from amniotic fluid
US8586357B2 (en) *	2003-12-23	2013-11-19	Viacyte, Inc.	Markers of definitive endoderm
US20050176139A1 (en)	2004-01-12	2005-08-11	Yao-Chang Chen	Placental stem cell and methods thereof
US20050266391A1 (en)	2004-01-15	2005-12-01	Bennett Brydon L	Methods for preserving tissue
US20080095749A1 (en)	2004-03-22	2008-04-24	Sudeepta Aggarwal	Mesenchymal stem cells and uses therefor
WO2005093044A1 (en)	2004-03-22	2005-10-06	Osiris Therapeutics, Inc.	Mesenchymal stem cells and uses therefor
US20050276792A1 (en)	2004-03-26	2005-12-15	Kaminski Joseph K	Systems and methods for providing a stem cell bank
WO2005105992A1 (en)	2004-04-21	2005-11-10	New York Eye & Ear Infirmary	Chondrocyte culture formulations
JP2006006249A (ja)	2004-06-28	2006-01-12	Hiroshima Univ	羊膜由来細胞の培養方法及びその利用
CN100564518C (zh)	2004-07-20	2009-12-02	成都军区昆明总医院	胎盘羊膜细胞提取物及其在间充质干细胞诱导分化中的应用
US7244759B2 (en)	2004-07-28	2007-07-17	Celgene Corporation	Isoindoline compounds and methods of making and using the same
US20080292597A1 (en)	2004-07-29	2008-11-27	David A Steenblock	Umbilical Cord Stem Cell Composition & Method of Treating Neurological Diseases
AU2005273077B2 (en) *	2004-08-16	2011-02-24	Cellresearch Corporation Pte Ltd	Isolation of stem/progenitor cells from amniotic membrane of umbilical cord.
WO2006028723A1 (en)	2004-09-03	2006-03-16	Moraga Biotechnology Inc.	Non-embryonic totipotent blastomer-like stem cells and methods therefor
EP1799812A4 (en)	2004-09-16	2009-09-09	Gamida Cell Ltd	EX VIVO CULTIVATION METHODS OF STEM CELLS AND PRECURSOR BY CO-CULTURE WITH MESENCHYMAL CELLS
US7909806B2 (en)	2004-09-23	2011-03-22	Anthrogenesis Corporation	Cord blood and placenta collection kit
US7147626B2 (en)	2004-09-23	2006-12-12	Celgene Corporation	Cord blood and placenta collection kit
CN102391981B (zh)	2004-09-24	2014-08-20	麦索布莱斯特公司	多能扩增间充质前体细胞子代(memp)及其应用
US20060069008A1 (en)	2004-09-28	2006-03-30	Sanjay Mistry	Treatment of neurological deficits in the striatum or substanta nigra pars compacta
US20060069009A1 (en)	2004-09-28	2006-03-30	Messina Darin J	Treatment of neurological deficits in the striatum or substanta nigra pars compacta
US8039258B2 (en)	2004-09-28	2011-10-18	Ethicon, Inc.	Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
WO2006101548A2 (en)	2004-12-21	2006-09-28	Ethicon, Inc.	Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
US20060166361A1 (en)	2004-12-21	2006-07-27	Agnieszka Seyda	Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
ES2621847T3 (es)	2004-12-23	2017-07-05	DePuy Synthes Products, Inc.	Células posparto derivadas de tejido de cordón umbilical, y métodos de elaboración y uso de las mismas
DK1835924T3 (da)	2004-12-23	2013-11-04	Ethicon Inc	Behandling af parkinsons sygdom og beslægtede sygdomme under anvendelse af postpartum opnåede celler
US20070041943A1 (en)	2004-12-29	2007-02-22	Children's Hospital Research	Expression of virus entry inhibitors and recombinant AAV thereof
WO2006074308A2 (en)	2005-01-07	2006-07-13	Wake Forest University Health Sciences	Regeneration of pancreatic islets by amniotic fluid stem cell therapy
WO2006091766A2 (en)	2005-02-24	2006-08-31	Jau-Nan Lee	Human trophoblast stem cells and use thereof
US20100028306A1 (en)	2005-03-31	2010-02-04	Stemnion, Inc.	Amnion-Derived Cell Compositions, Methods of Making and Uses Thereof
US20060222634A1 (en)	2005-03-31	2006-10-05	Clarke Diana L	Amnion-derived cell compositions, methods of making and uses thereof
EP2399991B1 (en)	2005-04-12	2017-09-27	Mesoblast, Inc.	Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
EP1871873A1 (en) *	2005-04-16	2008-01-02	Axordia Limited	Cytotrophoblast stem cell
JP4814226B2 (ja)	2005-04-28	2011-11-16	株式会社ステムセル研究所	移植用臓器の調製方法
WO2006121043A1 (ja)	2005-05-09	2006-11-16	Olympus Corporation	間葉系幹細胞の培養方法および生体組織補填体の製造方法
AU2006202209B2 (en)	2005-05-27	2011-04-14	Lifescan, Inc.	Amniotic fluid derived cells
NZ564563A (en) *	2005-06-10	2011-03-31	Celgene Corp	Human placental collagen compositions, processes for their preparation, methods of their use and kits comprising the compositions
BRPI0612121A2 (pt)	2005-06-30	2016-09-06	Anthrogenesis Corp	método de reparo de uma membrana timpânica que tenha uma deformidade, e, biotecido de colágeno
WO2007009061A2 (en)	2005-07-13	2007-01-18	Anthrogenesis Corporation	Ocular plug formed from placenta derived collagen biofabric
US7928280B2 (en)	2005-07-13	2011-04-19	Anthrogenesis Corporation	Treatment of leg ulcers using placenta derived collagen biofabric
WO2007011693A2 (en) *	2005-07-14	2007-01-25	Medistem Laboratories, Inc.	Compositions of placentally-derived stem cells for the treatment of cancer
US7923007B2 (en)	2005-08-08	2011-04-12	Academia Sinica	Brain tissue damage therapies
US20080226612A1 (en)	2005-08-19	2008-09-18	Bio Regenerate, Inc.	Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof
CA2856662C (en)	2005-10-13	2017-09-05	Anthrogenesis Corporation	Immunomodulation using placental stem cells
EP1934334A1 (en)	2005-10-13	2008-06-25	Anthrogenesis Corporation	Production of oligodendrocytes from placenta-derived stem cells
ZA200803930B (en) *	2005-10-13	2010-03-31	Anthrogenesis Corp	Immunomodulation using placental stem cells
CN100344757C (zh)	2005-10-18	2007-10-24	天津昂赛细胞基因工程有限公司	人胎盘、脐带间充质干细胞库及其构建方法
JP5289970B2 (ja)	2005-12-16	2013-09-11	エシコン・インコーポレイテッド	組織適合性不適合な移植における逆免疫反応を抑制するための組成物および方法
US8741638B2 (en)	2005-12-19	2014-06-03	DePuy Synthes Products, LLC	In vitro expansion of postpartum-derived cells in roller bottles
CN103173401A (zh)	2005-12-22	2013-06-26	简·恩尼斯	来自冷冻的脐带组织的活细胞
AU2006330409B2 (en)	2005-12-28	2012-07-19	Ethicon, Incorporated	Treatment of peripheral vascular disease using postpartum-derived cells
PT2471906T (pt)	2005-12-29	2019-02-06	Celularity Inc	Populações de células estaminais da placenta
WO2007079185A2 (en)	2005-12-29	2007-07-12	Anthrogenesis Corporation	Improved composition for collecting and preserving placental stem cells and methods of using the composition
CN101389754A (zh) *	2005-12-29	2009-03-18	人类起源公司	胎盘干细胞和第二来源干细胞的联合培养
US20070253931A1 (en)	2006-01-12	2007-11-01	Osiris Therapeutics, Inc.	Use of mesenchymal stem cells for treating genetic diseases and disorders
US20080286249A1 (en)	2006-01-12	2008-11-20	Varney Timothy R	Use of mesenchymal stem cells for treating genetic diseases and disorders
US20070258963A1 (en)	2006-01-13	2007-11-08	Osiris Therapeutics, Inc.	Mesenchymal stem cells expressing TNF-alpha receptors
CN100545260C (zh)	2006-01-13	2009-09-30	深圳市北科生物科技有限公司	人羊膜间充质干细胞的分离及培养方法及医用组合物
US9944900B2 (en)	2006-01-18	2018-04-17	Hemacell Perfusion	Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells
EP1986668B1 (en)	2006-01-23	2013-06-12	Athersys, Inc.	Mapc therapeutics without adjunctive immunosuppressive treatment
AU2007208367B2 (en)	2006-01-23	2013-05-16	Abt Holding Company	MAPC treatment of brain injuries and diseases
EP1845154A1 (en)	2006-04-12	2007-10-17	RNL Bio Co., Ltd.	Multipotent stem cells derived from placenta tissue and cellular therapeutic agents comprising the same
CA2909053C (en)	2006-05-11	2021-02-09	Cord Blood Science Inc.	Methods for collecting and using placenta cord blood stem cells
WO2007136673A2 (en)	2006-05-19	2007-11-29	Medistem Laboratories, Inc.	Treatment of disc degenerative disease and compositions for same
WO2007146106A2 (en)	2006-06-05	2007-12-21	Cryo- Cell International, Inc.	Procurement, isolation and cryopreservation of maternal placental cells
US20080050814A1 (en)	2006-06-05	2008-02-28	Cryo-Cell International, Inc.	Procurement, isolation and cryopreservation of fetal placental cells
WO2007146123A2 (en)	2006-06-09	2007-12-21	Anthrogenesis Corporation	Placental niche and use thereof to culture stem cells
US20070287176A1 (en)	2006-06-13	2007-12-13	Alireza Rezania	Chorionic villus derived cells
US8475788B2 (en)	2006-06-14	2013-07-02	Stemnion, Inc.	Methods of treating spinal cord injury and minimizing scarring
WO2007149548A2 (en)	2006-06-22	2007-12-27	Medistem Laboratories, Inc.	Treatment of erectile dysfunction by stem cell therapy
CA2656175C (en)	2006-06-26	2018-08-28	Lifescan, Inc.	Conditioned media obtained from amniotic fluid-derived cells for pluripotent stem cell culture
EP2089510B1 (en)	2006-06-28	2021-02-24	The University of Medicine and Dentistry of New Jersey	Amnion-derived stem cells and uses thereof
US7993918B2 (en)	2006-08-04	2011-08-09	Anthrogenesis Corporation	Tumor suppression using placental stem cells
US20090081171A1 (en)	2006-08-11	2009-03-26	Yu-Show Fu	Cell system for alleviating syndromes of Parkinson's disease in a mammal
WO2008021391A1 (en) *	2006-08-15	2008-02-21	Anthrogenesis Corporation	Umbilical cord biomaterial for medical use
US20080050347A1 (en)	2006-08-23	2008-02-28	Ichim Thomas E	Stem cell therapy for cardiac valvular dysfunction
US20120269774A1 (en)	2006-09-21	2012-10-25	Medistem Laboratories, Inc	Allogeneic stem cell transplants in non-conditioned recipients
WO2008042441A1 (en)	2006-10-03	2008-04-10	Anthrogenesis Corporation	Use of umbilical cord biomaterial for ocular surgery
US8071135B2 (en)	2006-10-04	2011-12-06	Anthrogenesis Corporation	Placental tissue compositions
ES2516698T3 (es)	2006-10-06	2014-10-31	Anthrogenesis Corporation	Composiciones de colágeno placentario (telopéptido) nativo
AU2007309447B2 (en)	2006-10-23	2014-04-03	Celularity Inc.	Methods and compositions for treatment of bone defects with placental cell populations
PL2089511T3 (pl)	2006-11-13	2015-02-27	Depuy Synthes Products Llc	Rozrost in vitro komórek pochodzących z tkanki pępowinowej wykorzystujących mikronośniki
US8241621B2 (en)	2006-12-18	2012-08-14	Medistem Laboratories	Stem cell mediated treg activation/expansion for therapeutic immune modulation
MX2009008559A (es)	2007-02-12	2009-08-21	Anthrogenesis Corp	Hepatocitos y condorcitos de celulas madre de la placenta adherentes, y poblaciones de celulas enriquecidas con celulas madre de la placenta cd34+, cd45-.
CN101657206B (zh)	2007-02-12	2013-07-03	人类起源公司	利用胎盘干细胞治疗炎性疾病
US20100172830A1 (en)	2007-03-29	2010-07-08	Cellx Inc.	Extraembryonic Tissue cells and method of use thereof
US20080254005A1 (en)	2007-04-06	2008-10-16	Medistem Labortories	Stem Cell Therapy for the Treatment of Autism and Other Disorders
CA2700613C (en)	2007-09-26	2022-09-20	Celgene Cellular Therapeutics	Angiogenic cells from human placental perfusate
EP3524253A1 (en)	2007-09-28	2019-08-14	Celularity, Inc.	Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
KR20100100855A (ko)	2007-11-07	2010-09-15	안트로제네시스 코포레이션	조산 합병증의 치료에 있어서의 제대혈의 용도
US8216997B2 (en)	2008-08-14	2012-07-10	Acceleron Pharma, Inc.	Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
MX339624B (es) *	2008-08-20	2016-06-02	Anthrogenesis Corp	Composiciones mejoradas de celulas y metodos para preparar las mismas.
WO2010021715A1 (en) *	2008-08-20	2010-02-25	Anthrogenesis Corporation	Treatment of stroke using isolated placental cells
ES2426241T3 (es)	2008-08-22	2013-10-22	Anthrogenesis Corporation	Métodos y composiciones para el tratamiento de defectos óseos con poblaciones de células placentarias
RU2562154C2 (ru)	2008-11-19	2015-09-10	Антродженезис Корпорейшн	Амниотические адгезивные клетки
EP2375907B1 (en)	2008-11-21	2019-02-27	Celularity, Inc.	Treatment of diseases, disorders or conditions of the lung using placental cells
WO2010141654A1 (en)	2009-06-05	2010-12-09	Anthrogenesis Corporation	Improved method of collecting placental cells
US8586360B2 (en) *	2009-07-02	2013-11-19	Anthrogenesis Corporation	Method of producing erythrocytes without feeder cells
EP3284818B1 (en)	2010-01-26	2022-03-09	Celularity Inc.	Treatment of bone-related cancers using placental stem cells
US20110280849A1 (en)	2010-03-26	2011-11-17	Anthrogenesis Corporation	Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
RS55287B1 (sr)	2010-04-07	2017-03-31	Anthrogenesis Corp	Angiogeneza korišćenjem matičnih ćelija iz placente
TW201138792A (en)	2010-04-08	2011-11-16	Anthrogenesis Corp	Treatment of sarcoidosis using placental stem cells
AU2011279201B2 (en)	2010-07-13	2016-01-21	Celularity Inc.	Methods of generating natural killer cells
AR084754A1 (es)	2010-12-30	2013-06-05	Anthrogenesis Corp	Composiciones que comprenden celulas madre de placenta y plasma rico en plaquetas, y sus metodos de uso
JP2014514245A (ja)	2010-12-30	2014-06-19	アントフロゲネシスコーポレーション	細胞を凍結保存及びカプセル封入する方法
AR084753A1 (es)	2010-12-30	2013-06-05	Anthrogenesis Corp	Composiciones que comprenden celulas adherentes derivadas del saco amniotico (amdac) y plasma rico en plaquetas (prp)
WO2012092485A1 (en)	2010-12-31	2012-07-05	Anthrogenesis Corporation	Enhancement of placental stem cell potency using modulatory rna molecules
WO2012166844A2 (en)	2011-06-01	2012-12-06	Anthrogenesis Corporation	Treatment of pain using placental stem cells

2006
- 2006-12-28 PT PT12150928T patent/PT2471906T/pt unknown
- 2006-12-28 CA CA2957336A patent/CA2957336C/en active Active
- 2006-12-28 CN CN201310024293.2A patent/CN103146640B/zh not_active Expired - Fee Related
- 2006-12-28 PT PT12150924T patent/PT2471905T/pt unknown
- 2006-12-28 NZ NZ595786A patent/NZ595786A/xx not_active IP Right Cessation
- 2006-12-28 KR KR1020177008335A patent/KR101900809B1/ko active Active
- 2006-12-28 PL PL12150934T patent/PL2471907T3/pl unknown
- 2006-12-28 EP EP12150919.4A patent/EP2471904B1/en active Active
- 2006-12-28 NZ NZ622377A patent/NZ622377A/en not_active IP Right Cessation
- 2006-12-28 PL PL12150924T patent/PL2471905T3/pl unknown
- 2006-12-28 CA CA2635253A patent/CA2635253C/en active Active
- 2006-12-28 DK DK12150919.4T patent/DK2471904T3/en active
- 2006-12-28 US US11/648,804 patent/US20080032401A1/en not_active Abandoned
- 2006-12-28 PT PT12150919T patent/PT2471904T/pt unknown
- 2006-12-28 KR KR1020217031368A patent/KR20210122908A/ko not_active Ceased
- 2006-12-28 CN CN201810489408.8A patent/CN108559725A/zh active Pending
- 2006-12-28 ES ES12150912.9T patent/ES2671355T3/es active Active
- 2006-12-28 EP EP12150924.4A patent/EP2471905B1/en active Active
- 2006-12-28 ES ES12150924T patent/ES2703502T3/es active Active
- 2006-12-28 JP JP2008548745A patent/JP5550235B2/ja not_active Expired - Fee Related
- 2006-12-28 EP EP12150912.9A patent/EP2471903B1/en active Active
- 2006-12-28 PL PL12150912T patent/PL2471903T3/pl unknown
- 2006-12-28 ES ES06848281.9T patent/ES2549111T3/es active Active
- 2006-12-28 PT PT121509129T patent/PT2471903T/pt unknown
- 2006-12-28 KR KR1020197025129A patent/KR20190104428A/ko not_active Ceased
- 2006-12-28 DK DK12150934.3T patent/DK2471907T3/en active
- 2006-12-28 EP EP18196002.2A patent/EP3486314B1/en active Active
- 2006-12-28 NZ NZ712789A patent/NZ712789A/en not_active IP Right Cessation
- 2006-12-28 PL PL12150919T patent/PL2471904T3/pl unknown
- 2006-12-28 KR KR1020157020367A patent/KR101722577B1/ko not_active Expired - Fee Related
- 2006-12-28 CN CN201210477851.6A patent/CN103060263B/zh not_active Expired - Fee Related
- 2006-12-28 KR KR1020187026653A patent/KR20180105266A/ko not_active Ceased
- 2006-12-28 CN CN201310405648.2A patent/CN103525758B/zh not_active Expired - Fee Related
- 2006-12-28 AU AU2006332678A patent/AU2006332678B2/en not_active Ceased
- 2006-12-28 NZ NZ569562A patent/NZ569562A/en not_active IP Right Cessation
- 2006-12-28 KR KR1020207030297A patent/KR20200123283A/ko not_active Ceased
- 2006-12-28 ES ES12150919T patent/ES2711278T3/es active Active
- 2006-12-28 EP EP12150928.5A patent/EP2471906B1/en active Active
- 2006-12-28 WO PCT/US2006/049491 patent/WO2007079183A2/en active Application Filing
- 2006-12-28 PT PT12150934T patent/PT2471907T/pt unknown
- 2006-12-28 EP EP06848281.9A patent/EP1976977B1/en active Active
- 2006-12-28 EP EP12150934.3A patent/EP2471907B1/en active Active
- 2006-12-28 KR KR1020237019606A patent/KR20230091193A/ko not_active Ceased
- 2006-12-28 DK DK12150924.4T patent/DK2471905T3/da active
- 2006-12-28 US US11/648,813 patent/US8057788B2/en not_active Expired - Lifetime
- 2006-12-28 CN CN200680053575.3A patent/CN101395266B/zh not_active Expired - Fee Related
- 2006-12-28 KR KR1020087018508A patent/KR101585241B1/ko active Active
- 2006-12-28 KR KR1020227015349A patent/KR20220063304A/ko not_active Ceased
- 2006-12-28 DK DK12150928.5T patent/DK2471906T3/en active
- 2006-12-28 DK DK12150912.9T patent/DK2471903T3/en active
- 2006-12-28 PL PL06848281T patent/PL1976977T3/pl unknown
- 2006-12-28 PL PL12150928T patent/PL2471906T3/pl unknown
- 2006-12-28 ES ES12150934T patent/ES2706726T3/es active Active
- 2006-12-28 ES ES12150928T patent/ES2708933T3/es active Active
- 2006-12-29 PE PE2006001722A patent/PE20080146A1/es not_active Application Discontinuation
2008
- 2008-06-25 MX MX2020001944A patent/MX2020001944A/es unknown
- 2008-06-25 MX MX2013009297A patent/MX338534B/es unknown
- 2008-06-25 MX MX2014002006A patent/MX348414B/es unknown
- 2008-06-25 MX MX2018012512A patent/MX2018012512A/es unknown
- 2008-06-26 IL IL192457A patent/IL192457A0/en active IP Right Grant
2010
- 2010-06-11 ZA ZA2010/04182A patent/ZA201004182B/en unknown
- 2010-07-30 US US12/848,007 patent/US8202703B2/en active Active
2012
- 2012-05-16 US US13/473,509 patent/US8591883B2/en active Active
- 2012-05-24 US US13/480,370 patent/US8691217B2/en active Active
- 2012-11-20 IL IL243876A patent/IL243876B/en active IP Right Grant
- 2012-11-20 IL IL223156A patent/IL223156A0/en active IP Right Grant
- 2012-11-22 IL IL223194A patent/IL223194A/en active IP Right Grant
2013
- 2013-01-10 JP JP2013002575A patent/JP5739918B2/ja not_active Expired - Fee Related
- 2013-10-29 HK HK13112141.8A patent/HK1184817A1/zh not_active IP Right Cessation
2014
- 2014-02-14 US US14/181,159 patent/US9078898B2/en active Active
2015
- 2015-06-10 US US14/735,727 patent/US10383897B2/en active Active
2016
- 2016-01-31 IL IL243876A patent/IL243876A0/en unknown
2017
- 2017-05-08 ZA ZA2017/03181A patent/ZA201703181B/en unknown
2019
- 2019-05-28 IL IL266958A patent/IL266958A/en unknown

Also Published As

Publication number	Publication date
EP2471903A3 (en)	2013-02-27
US8202703B2 (en)	2012-06-19
KR20210122908A (ko)	2021-10-12
EP2471906A2 (en)	2012-07-04
EP2471904B1 (en)	2018-10-24
NZ595786A (en)	2013-05-31
KR20170037689A (ko)	2017-04-04
AU2006332678A1 (en)	2007-07-12
ES2703502T3 (es)	2019-03-11
CN103146640A (zh)	2013-06-12
ES2549111T3 (es)	2015-10-23
EP2471906A3 (en)	2012-10-31
US9078898B2 (en)	2015-07-14
EP2471907A2 (en)	2012-07-04
CN101395266A (zh)	2009-03-25
CN101395266B (zh)	2018-06-15
ZA201004182B (en)	2013-02-27
KR101722577B1 (ko)	2017-04-03
US20130028871A1 (en)	2013-01-31
AU2006332678B2 (en)	2013-12-05
EP2471905B1 (en)	2018-09-05
PL2471906T3 (pl)	2019-09-30
EP2471907B1 (en)	2018-09-26
PE20080146A1 (es)	2008-02-11
EP3486314B1 (en)	2023-03-22
KR101900809B1 (ko)	2018-09-20
ES2671355T3 (es)	2018-06-06
PL2471907T3 (pl)	2019-07-31
KR20180105266A (ko)	2018-09-27
PT2471904T (pt)	2019-02-25
NZ569562A (en)	2012-04-27
CA2635253C (en)	2017-03-14
PL2471903T3 (pl)	2018-09-28
US10383897B2 (en)	2019-08-20
MX338534B (es)	2016-04-21
MX2018012512A (es)	2020-11-12
CA2957336A1 (en)	2007-07-12
EP2471904A2 (en)	2012-07-04
CN103060263A (zh)	2013-04-24
PT2471903T (pt)	2018-05-18
ZA201703181B (en)	2021-08-25
DK2471907T3 (en)	2019-01-21
CA2957336C (en)	2023-09-26
MX2020001944A (es)	2020-07-13
KR20150092353A (ko)	2015-08-12
KR101585241B1 (ko)	2016-01-13
US8591883B2 (en)	2013-11-26
EP2471903A2 (en)	2012-07-04
MX348414B (es)	2017-06-12
DK2471904T3 (en)	2019-02-18
WO2007079183A3 (en)	2007-11-15
EP1976977B1 (en)	2015-07-08
CN103146640B (zh)	2015-09-09
EP1976977A2 (en)	2008-10-08
EP2471905A3 (en)	2012-10-31
NZ622377A (en)	2015-10-30
US20100297689A1 (en)	2010-11-25
IL223156A0 (en)	2012-12-31
PL1976977T3 (pl)	2015-12-31
PL2471904T3 (pl)	2019-08-30
ES2711278T3 (es)	2019-04-30
JP2009521929A (ja)	2009-06-11
DK2471903T3 (en)	2018-05-28
IL223194A (en)	2015-05-31
EP2471905A2 (en)	2012-07-04
DK2471905T3 (da)	2019-01-02
US8691217B2 (en)	2014-04-08
KR20220063304A (ko)	2022-05-17
ES2708933T3 (es)	2019-04-12
KR20200123283A (ko)	2020-10-28
KR20190104428A (ko)	2019-09-09
KR20230091193A (ko)	2023-06-22
NZ712789A (en)	2017-06-30
EP3486314A3 (en)	2019-08-07
US20080032401A1 (en)	2008-02-07
JP2013099343A (ja)	2013-05-23
EP3486314A2 (en)	2019-05-22
CN103525758B (zh)	2018-02-13
KR20080081083A (ko)	2008-09-05
PT2471906T (pt)	2019-02-06
EP2471906B1 (en)	2018-10-10
US20130022581A1 (en)	2013-01-24
CN108559725A (zh)	2018-09-21
DK2471906T3 (en)	2019-02-04
US20140377230A1 (en)	2014-12-25
HK1184817A1 (zh)	2014-01-30
JP5739918B2 (ja)	2015-06-24
CN103525758A (zh)	2014-01-22
EP2471903B1 (en)	2018-02-14
IL192457A0 (en)	2009-02-11
IL243876A0 (en)	2016-04-21
ES2706726T3 (es)	2019-04-01
IL223194A0 (en)	2012-12-31
PT2471907T (pt)	2019-01-28
WO2007079183A2 (en)	2007-07-12
PL2471905T3 (pl)	2019-08-30
JP5550235B2 (ja)	2014-07-16
IL266958A (en)	2019-07-31
US20160129048A1 (en)	2016-05-12
US8057788B2 (en)	2011-11-15
CA2635253A1 (en)	2007-07-12
CN103060263B (zh)	2016-03-16
US20070275362A1 (en)	2007-11-29
IL243876B (en)	2019-06-30
EP2471904A3 (en)	2012-10-31
EP2471907A3 (en)	2012-10-31

Publication	Publication Date	Title
IL266958A (en)	2019-07-31	Stem cell cultures from placenta
HK1225753A1 (zh)	2017-09-15	使用胎盤幹細胞的免疫調節
GB2441530B (en)	2009-09-23	Stem Cells
SI1780267T1 (sl)	2016-03-31	Celice, dobljene iz amnijske tekočine
GB0709533D0 (en)	2007-06-27	Platelets from stem cells
EP1897159A4 (en)	2009-01-28	LEAD-ALKALI BATTERY
GB2425129B (en)	2008-11-05	Cytotrophoblast stem cell
ZA200803930B (en)	2010-03-31	Immunomodulation using placental stem cells
GB0503918D0 (en)	2005-04-06	Cell
GB0511723D0 (en)	2005-07-13	Placental stem cells
GB0522564D0 (en)	2005-12-14	Cells
GB0500869D0 (en)	2005-02-23	Stem cells
GB0410910D0 (en)	2004-06-16	Stem cells
GB0403074D0 (en)	2004-03-17	Stem cells
GB0505745D0 (en)	2005-04-27	Cell lines
GB0509266D0 (en)	2005-06-15	Battery
GB0500528D0 (en)	2005-02-16	Battery
GB0501216D0 (en)	2005-03-02	Cell adhesion
GB0515423D0 (en)	2005-08-31	Cell adhesion
GB0421753D0 (en)	2004-11-03	Cell line
GB0425767D0 (en)	2004-12-22	Cell line
GB0427830D0 (en)	2005-01-19	Cell line